Similar articles

• Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).

  Björck L, Wallentin L, Stenestrand U, Lappas G, Rosengren A. Björck L, et al. Arch Intern Med. 2010 Aug 9;170(15):1375-81. doi: 10.1001/archinternmed.2010.203. Arch Intern Med. 2010. PMID: 20696964
• Re: Secondary medical prevention in patients with peripheral arterial disease.

  Schouten O, Welten GM, Bax JJ, Poldermans D. Schouten O, et al. Eur J Vasc Endovasc Surg. 2008 Jan;35(1):59-60. doi: 10.1016/j.ejvs.2007.07.006. Epub 2007 Aug 27. Eur J Vasc Endovasc Surg. 2008. PMID: 17719805 No abstract available.
• Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.

  Skinner JS, Minhas R. Skinner JS, et al. Heart. 2007 Jul;93(7):864-6. doi: 10.1136/hrt.2007.124305. Heart. 2007. PMID: 17569812 Free PMC article. No abstract available.
• [Secondary prevention after myocardial infarction].

  Czuriga I. Czuriga I. Orv Hetil. 2002 Sep 15;143(37):2117-28. Orv Hetil. 2002. PMID: 12434627 Review. Hungarian.
• Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.

  Skinner JS, Cooper A, Feder GS; Guideline Development Group. Skinner JS, et al. Heart. 2007 Jul;93(7):862-4. doi: 10.1136/hrt.2007.124321. Heart. 2007. PMID: 17569811 Free PMC article. Review.